Pan J, Deng B, Liu S, et al. Efficacy and safety of CD22-directed CAR-T cell therapy in 15 pediatric refractory or relapsed B acute lymphoblastic leukemia patients. EHA 2018, abstract 832.
Ibrutinib plus R-CHOP bij jongere patiënt met ‘non-germinal center B-cell’ DLBCL?
jun 2019 | Lymfoom